Woodline Partners’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-29,624
| Closed | -$476K | – | 980 |
|
|
2024
Q3 | $476K | Buy |
29,624
+8,876
| +43% | +$143K | ﹤0.01% | 537 |
|
|
2024
Q2 | $506K | Sell |
20,748
-19,454
| -48% | -$475K | ﹤0.01% | 497 |
|
|
2024
Q1 | $2.89M | Buy |
40,202
+15,052
| +60% | +$1.08M | 0.03% | 405 |
|
|
2023
Q4 | $5M | Buy |
25,150
+18,900
| +302% | +$3.76M | 0.05% | 317 |
|
|
2023
Q3 | $831K | Hold |
6,250
| – | – | 0.01% | 460 |
|
|
2023
Q2 | $935K | Buy |
+6,250
| New | +$935K | 0.01% | 487 |
|
|
2023
Q1 | – | Sell |
-33,018
| Closed | -$5.23M | – | 756 |
|
|
2022
Q4 | $5.23M | Sell |
33,018
-118,043
| -78% | -$18.7M | 0.07% | 307 |
|
|
2022
Q3 | $29.1M | Buy |
151,061
+43,685
| +41% | +$8.41M | 0.41% | 60 |
|
|
2022
Q2 | $15.7M | Buy |
107,376
+62,571
| +140% | +$9.14M | 0.24% | 127 |
|
|
2022
Q1 | $7.88M | Buy |
+44,805
| New | +$7.88M | 0.13% | 195 |
|
|
2020
Q4 | – | Sell |
-8,413
| Closed | -$2.17M | – | 265 |
|
|
2020
Q3 | $2.17M | Buy |
+8,413
| New | +$2.17M | 0.07% | 161 |
|